Warning letter
North Texas IRB: warning letter of Apr 14, 2003
FDA warning letter UCM147431 · Center for Biologics Evaluation and Research
Key facts
| Reference number | UCM147431 |
|---|---|
| Company | North Texas IRB |
| Subject | Institutional Review Board |
| Issue date | Apr 14, 2003 |
| Posted date | Apr 14, 2003 |
| Issuing office | Center for Biologics Evaluation and Research |
| Product type | Devices |
| CFR sections cited | 50.25, 56, 56.109, 56.111, 56.115, 56.120, 50, 56.106(a), 56.107(e), 56.108(a), 56.115(b), 56.120(b)(1) and 3 more |
| Country | 3 |
| Letter on fda.gov | web.archive.org |
At a glance
- 10–99 CFR sections cited
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: